返回 Agenda
New Collaboration Models with Regulators and Patients
Session Chair(s)
Brian Mayhew, MA, MBA
Executive Director, Regulatory Policy
Novartis Pharmaceuticals Corporation, United States
This session will explore how the utilisation of advances in technology (such as big data, wearables, cloud computing) will open new opportunities & challenges for collaboration between companies with regulators, payers and patients: Is the present interaction model appropriate; should authorities be involved earlier in data collection & analysis, and how will this change patient engagement?
Speaker(s)
Scott Askin, MSC
Novartis Pharma AG, Switzerland
Global Program Regulatory Director
Regulator Perspective on the Use of New Technology for Evidence Generation on Regulatory Decision Making
Alison Cave, PHD
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Chief Safety Officer
Patient Perspective
Trishna Bharadia
The Spark Global, United Kingdom
Patient Advocate, International Speaker, Writer, Advisor and Content Reviewer